New Target for Minoxidil in the Treatment of Androgenetic Alopecia.

Yuqing ShenYuqi ZhuLi ZhangJiayi Sun Bo Xie Hongyan ZhangXiuzu Song

Published in: Drug design, development and therapy (2023)

Minoxidil may act by altering hormonal and enzymatic pathways. Our study finds two new targets (CYP17A1, CYP19A1) of minoxidil and demonstrates that minoxidil inhibits AR. These targets may provide new ideas for drug research.

Keyphrases

metabolic syndrome
adipose tissue
adverse drug
replacement therapy